» Articles » PMID: 11581222

Slow and Fast Rod ERG Pathways in Patients with X-linked Complete Stationary Night Blindness Carrying Mutations in the NYX Gene

Overview
Specialty Ophthalmology
Date 2001 Oct 3
PMID 11581222
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To study the slow and fast rod signals of the scotopic 15-Hz flicker ERG in patients carrying mutations in the NYX gene, which has been recently identified as the cause of the complete form of congenital stationary night blindness, CSNB1.

Methods: Twenty eyes of 11 patients with CSNB1 who had nondetectable standard ERG rod b-waves were involved in the study. Scotopic ERG response amplitudes and phases to flicker intensities ranging from -3.37 to -0.57 log scotopic trolands. sec (scot td. sec) were measured at a flicker frequency of 15 Hz. ERG signals to flicker intensities between -3.37 and -1.97 and between -1.17 and -0.57 log scot td. sec were considered to represent primarily the slow and fast rod ERG pathway, respectively. Additionally, standard ERGs were performed. Twenty-two normal volunteers served as control subjects.

Results: For the slow rod ERG pathway, all patients exhibited ERG signals that were indistinguishable from noise. Accordingly, there was no systematic phase behavior for the slow rod signals. For the fast rod ERG pathway, the signals were significantly above noise, but they were significantly reduced in amplitude and advanced in phase.

Conclusions: There is evidence that the slow and the fast rod ERG signals can be attributed to the rod bipolar-AII cell pathway and the rod-cone-coupling pathway, respectively. The current study provides evidence to suggest that a defective NYX gene product (nyctalopin) prevents detectable signal transmission through ON rod bipolar cells, but there is a residual transmission through rod-cone gap junctions in CSNB1, possibly through the OFF cone pathway.

Citing Articles

Post-developmental plasticity of the primary rod pathway allows restoration of visually guided behaviors.

Cao Y, Fajardo D, Guerrero-Given D, Samuel M, Ohtsuka T, Boye S Curr Biol. 2022; 32(22):4783-4796.e3.

PMID: 36179691 PMC: 9691582. DOI: 10.1016/j.cub.2022.09.016.


Involvement of transient receptor potential channels in ocular diseases: a narrative review.

Yang T, Yu Y, Yang J, Li J, Zhu J, Vieira J Ann Transl Med. 2022; 10(15):839.

PMID: 36034986 PMC: 9403939. DOI: 10.21037/atm-21-6145.


Small Leucine-Rich Proteoglycans (SLRPs) in the Retina.

Low S, Connor T, Kassem I, Costakos D, Chaurasia S Int J Mol Sci. 2021; 22(14).

PMID: 34298915 PMC: 8305803. DOI: 10.3390/ijms22147293.


CACNA1S expression in mouse retina: Novel isoforms and antibody cross-reactivity with GPR179.

Hasan N, Ray T, Gregg R Vis Neurosci. 2016; 33:E009.

PMID: 27471951 PMC: 6815669. DOI: 10.1017/S0952523816000055.


Ultrastructural localization of GPR179 and the impact of mutant forms on retinal function in CSNB1 patients and a mouse model.

Klooster J, van Genderen M, Yu M, Florijn R, Riemslag F, Bergen A Invest Ophthalmol Vis Sci. 2013; 54(10):6973-81.

PMID: 24084093 PMC: 3808102. DOI: 10.1167/iovs.13-12293.